Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02803203 |
| Title | Osimertinib and Bevacizumab as Treatment for EGFR-mutant Lung Cancers |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Memorial Sloan Kettering Cancer Center |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Memoral Sloan Kettering Basking Ridge | Basking Ridge | New Jersey | United States | Details | ||
| Memorial Sloan Kettering Monmouth | Middletown | New Jersey | 07748 | United States | Details | |
| Memorial Sloan Kettering Bergen | Montvale | New Jersey | 07645 | United States | Details | |
| Memorial Sloan Kettering commack | Commack | New York | 11725 | United States | Details | |
| Memorial Sloan Kettering Westchester | Harrison | New York | 10604 | United States | Details | |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | United States | Details | |
| Memorial Sloan Kettering Nassau | Uniondale | New York | 11553 | United States | Details |